Regentis Biomaterials Strikes Distribution Deal With AMI Medical Technologies To Commercialize GelrinC In Israel
Benzinga Newsdesk 7 hours ago
News
Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced that it has entered into a
Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced that it has entered into a four-year exclusive distribution agreement with AMI Medical Technologies Ltd. ("AMI"), a leading Israeli medical technology distributor, for the commercialization of GelrinC®, Regentis' proprietary implant for the repair of damaged knee cartilage, in Israel.